HCID 71522964, 화합물 → 5-chloro-N-(5-chlorothiazol-2-yl)-1'-formylspiro[indoline-3,3'-pyrrolidine]-1-carboxamide

HRID 1411239노트

반응식

HRID 1411239 반응식
[Cl:1][C:2]1[CH:3]=[C:4]2[C:10]3([CH2:14][CH2:13][NH:12][CH2:11]3)[CH2:9][N:8]([C:15]([NH:17][C:18]3[S:19][C:20]([Cl:23])=[CH:21][N:22]=3)=[O:16])[C:5]2=[CH:6][CH:7]=1.BrC1C=C2C3(CCNC3)CN([C:38](NC3SC(Cl)=CN=3)=[O:39])C2=CC=1>>[Cl:1][C:2]1[CH:3]=[C:4]2[C:10]3([CH2:14][CH2:13][N:12]([CH:38]=[O:39])[CH2:11]3)[CH2:9][N:8]([C:15]([NH:17][C:18]3[S:19][C:20]([Cl:23])=[CH:21][N:22]=3)=[O:16])[C:5]2=[CH:6][CH:7]=1

참가 물질

3

반응물 2

HCID 71522964HCID 71522964, 화합물HCID 904492715-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3'-pyrrolidine]-1-carboxamide

생성물 1

HCID 904493375-chloro-N-(5-chlorothiazol-2-yl)-1'-formylspiro[indoline-3,3'-pyrrolidine]-1-carboxamide

실험 절차

The captioned compound was obtained in the form of a white solid by performing the same reactions and/or treatments as those in Example 23, with the exception that the 5-chloro-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide obtained as an intermediate of Example 39 was used instead of 5-bromo-N-(5-chlorothiazol-2-yl)spiro[indoline-3,3′-pyrrolidine]-1-carboxamide.

후처리

  1. customThe captioned compound was obtained in the form of a white solid

출처 및 근거

ORD 기록
ord-0d133a99ce85459a830b029ebd722359
출처 데이터셋
uspto-grants-2014_12
특허 번호
US08921576B2

반응 노트

불러오는 중…